Reported end date passed· Health
COVID-19: Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility
The project will support the procurement and delivery of safe and effective vaccines against COVID-19 through APVAX's RRC in compliance with ADB's vaccine eligibility criteria to the country. It aims to finance the procurement of about 15.9 million doses of vaccines, which will be administered to about 6.8 million Nepalese by 2024, with data collected and disaggregated by sex and age.
Source-reported status: completed. Timeline labels use reported dates and do not verify current activity.
Reported by Asian Development Bank
Overview
About this project
The project will support the procurement and delivery of safe and effective vaccines against COVID-19 through APVAX's RRC in compliance with ADB's vaccine eligibility criteria to the country. It aims to finance the procurement of about 15.9 million doses of vaccines, which will be administered to about 6.8 million Nepalese by 2024, with data collected and disaggregated by sex and age.
Field coverage
100% complete
Completeness measures the presence of project fields. It is not a verification score. Multiple evidence versions can come from the same feed, and feeds can reproduce the same publisher's data.
Core project fields are present in the source-backed record.
Report an update or correctionReported disbursement / budget
51.2%USD 84.5M reported disbursed against USD 165.0M reported budget. This financial ratio does not measure implementation or outcomes.
Provenance
Original project evidence
1 distinct source feed across 2 recorded evidence versions. These are not independent confirmations. Links below show the latest available version for each source page, up to 50 pages.
- iati ↗
https://d-portal.org/ctrack.html?aid=XM-DAC-46004-55084-001-LN4088
Retrieved Oct 27, 2026 · Last checked Oct 27, 2026
Alignment